U.S. Bancorp is experiencing positive momentum, with a 21.5% stock increase over six months and strong net interest income growth projected despite falling interest rates. Analysts anticipate a 10.3% ...
Bayer’s AskBio unit has reported the first clinical data for its congestive heart failure gene therapy, showing preliminary signs of efficacy with no serious adverse events linked to the treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback